Kerstin Dolph
Windham, New Hampshire, United States
2K followers
500+ connections
Windham, New Hampshire, United States
2K followers
500+ connections
Activity
-
Our extensive concept-to-cure portfolio provides dependable off-the-shelf plasmid and viral vector products, along with customized packaging and…
Our extensive concept-to-cure portfolio provides dependable off-the-shelf plasmid and viral vector products, along with customized packaging and…
Liked by Kerstin Dolph
-
Save your seat for the 2024 European Cell & Gene Therapy Summit, October 15, in London: https://okt.to/TfaSub 💡 Learn how to overcome adversity…
Save your seat for the 2024 European Cell & Gene Therapy Summit, October 15, in London: https://okt.to/TfaSub 💡 Learn how to overcome adversity…
Liked by Kerstin Dolph
-
At Charles River Labs, we are proud to contribute to the fight against cancer. In 2023 alone, we played a role in the development of 87% of all…
At Charles River Labs, we are proud to contribute to the fight against cancer. In 2023 alone, we played a role in the development of 87% of all…
Liked by Kerstin Dolph
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Languages
-
English
-
-
German
-
More activity by Kerstin
-
Don’t miss this webinar on HEK293 cell banking!
Don’t miss this webinar on HEK293 cell banking!
Liked by Kerstin Dolph
-
I will be attending this year’s Meeting on the Mesa event during October 7-9! As a concept to cure provider, we have worked on 85% of the drugs…
I will be attending this year’s Meeting on the Mesa event during October 7-9! As a concept to cure provider, we have worked on 85% of the drugs…
Liked by Kerstin Dolph
-
Matthew Hewitt and industry experts discuss how advancements in technology are reshaping the roles and capabilities of CDMOs and CROs in the drug…
Matthew Hewitt and industry experts discuss how advancements in technology are reshaping the roles and capabilities of CDMOs and CROs in the drug…
Shared by Kerstin Dolph
-
Looking forward to this event with Ori Biotech's Jason C. Foster which will happen September 17th in Boston. If you are attending the CAR-TCR meeting…
Looking forward to this event with Ori Biotech's Jason C. Foster which will happen September 17th in Boston. If you are attending the CAR-TCR meeting…
Liked by Kerstin Dolph
-
With over 20 years of cell and gene therapy development experience, we’ve launched our off-the-shelf plasmid and viral vector products and services…
With over 20 years of cell and gene therapy development experience, we’ve launched our off-the-shelf plasmid and viral vector products and services…
Liked by Kerstin Dolph
-
As the parent of a child with FOXG1 Syndrome, Nasha Fitter is leading the charge to find a treatment for her daughter and other children with…
As the parent of a child with FOXG1 Syndrome, Nasha Fitter is leading the charge to find a treatment for her daughter and other children with…
Liked by Kerstin Dolph
-
Excited to announce that I'll be speaking at the upcoming BioTools Innovator Webinar on "Market Research and Analysis; Go-To-Market Strategies" with…
Excited to announce that I'll be speaking at the upcoming BioTools Innovator Webinar on "Market Research and Analysis; Go-To-Market Strategies" with…
Liked by Kerstin Dolph
-
The Nanoscope Therapeutics Inc. team was excited to be in Stockholm last week for the ASRS – American Society of Retina Specialists Annual Scientific…
The Nanoscope Therapeutics Inc. team was excited to be in Stockholm last week for the ASRS – American Society of Retina Specialists Annual Scientific…
Liked by Kerstin Dolph
-
We are looking for a multi-site EHS&S Manager for our Rockville/Hanover, MD sites. Come join our team! If it's not for you, please share so we can…
We are looking for a multi-site EHS&S Manager for our Rockville/Hanover, MD sites. Come join our team! If it's not for you, please share so we can…
Liked by Kerstin Dolph
-
Learn more about our collaboration with @FOXG1 Research Foundation, a parent-led global organization driving research to cure FOXG1 syndrome and…
Learn more about our collaboration with @FOXG1 Research Foundation, a parent-led global organization driving research to cure FOXG1 syndrome and…
Shared by Kerstin Dolph
-
Andrew Frazer discusses how Charles River's CGT portfolio leverages established platforms and processes to reliably support developers, such as…
Andrew Frazer discusses how Charles River's CGT portfolio leverages established platforms and processes to reliably support developers, such as…
Shared by Kerstin Dolph
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More